Complete Filing Data
Brenmiller Energy Ltd. reported Research And Development Expense of $3.96 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Brenmiller Energy Ltd. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$13.9M | -$6.8M | -$9.6M | -$11.1M | -$11.0M | -$9.5M |
| Research And Development Expense | $4.0M | $3.6M | $3.2M | $4.7M | $3.7M | $3.9M |
| General And Administrative Expense | $4.3M | $4.6M | $4.6M | $4.4M | $2.5M | $1.5M |
| Other Nonoperating Income Expense | -$670.0K | $4.0M | $312.0K | $683.0K | -$145.0K | |
| Operating Income Loss | -$12.7M | -$10.6M | -$9.9M | -$11.7M | -$10.9M | |
| Cost Of Revenue | $3.6M | $985.0K | $1.6M | $1.9M | $4.1M | |
| Comprehensive Income Net Of Tax | -$13.9M | -$6.8M | -$10.1M | -$11.9M | -$11.0M | |
| Sales And Marketing Expense | $1.2M | $747.0K | $370.0K | |||
| Cumulative Gain Loss Previously Recognised In Other Comprehensive Income Arising From Reclassification Of Financial Assets Out Of Fair Value Through Other Comprehensive Income Into Fair Value Through Profit Or Loss Measurement Category | -$529.0K | -$14.0K | -$64.0K | |||
| Cost Of Sales | $1.9M | $4.1M | $122.0K | |||
| Comprehensive Income | -$11.6M | -$10.4M | -$9.5M | |||
| Adjustments Fo Increasedecrease In Research And Development Expenses Due To Royalty Obligation | $175.0K | -$13.0K | $1.8M | |||
| Revenues | $387.0K | $621.0K | $1.5M | $395.0K | ||
| Revenue | $387.0K | $621.0K | $1.5M | $395.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $3.5M | $4.5M | $2.9M | $4.6M | $7.7M | $2.5M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $4.9M | $4.1M | $3.2M | $6.5M | $8.3M | $2.3M | |
| Liabilities | $9.0M | $7.4M | $7.7M | $7.8M | $9.1M | ||
| Assets | $12.5M | $11.9M | $10.6M | $12.5M | $14.6M | ||
| Equity | $3.5M | $4.5M | $2.9M | $4.6M | $7.7M | $2.5M | |
| Cash And Cash Equivalents | $6.5M | $8.3M | $2.3M | $352.0K | |||
| Cash And Cash Equivalents At Carrying Value | $4.9M | $4.1M | $3.2M | $6.5M | $8.3M | ||
| Restricted Cash And Cash Equivalents | $36.0K | $29.0K | $34.0K | $34.0K | $47.0K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $703.0K | $1.0M | -$3.2M | -$1.9M | $6.0M | ||
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $39.0K | $47.0K | $23.0K | ||||
| Cash Flows From Used In Operations | -$7.7M | -$9.3M | -$3.5M | ||||
| Cash Flows From Used In Operating Activities | -$10.1M | -$8.0M | -$3.4M | ||||
| Cash Flows From Used In Investing Activities | -$1.4M | -$238.0K | -$360.0K | ||||
| Cash Flows From Used In Financing Activities | $10.5M | $14.2M | $5.7M | ||||
| Amortization Of Rightofuse Assets | $535.0K | $471.0K | $458.0K | ||||
| Adjustments For Increase Decrease In Other Liabilities | -$895.0K | $898.0K | $744.0K | ||||
| Adjustments For Decrease Increase In Trade And Other Receivables | -$610.0K | -$98.0K | -$205.0K | ||||
| Recognition Of Lease Liability And Rightofuse Asset | $601.0K | $789.0K | $777.0K | ||||
| Grants Recognized As Liability For Royalties | -$94.0K | $314.0K | $24.0K | ||||
| Repayments Of Royalties Liability | -$85.0K | -$12.0K | |||||
| Cash Flows From Used In Decrease Increase In Restricted Cash And Cash Equivalents | $136.0K | $2.0K | $58.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $1.2M | $1.4M | $1.8M | $1.5M | $236.0K | |
| Payments To Acquire Property Plant And Equipment | $13.0K | $37.0K | $33.0K | $39.0K | $47.0K | |
| Payments Of Stock Issuance Costs | $564.0K | $466.0K | $176.0K | $297.0K | $434.0K | |
| Net Cash Provided By Used In Operating Activities | -$10.4M | -$9.5M | -$6.9M | -$11.7M | -$8.5M | |
| Net Cash Provided By Used In Investing Activities | -$398.0K | -$422.0K | -$2.6M | -$1.4M | -$248.0K | |
| Net Cash Provided By Used In Financing Activities | $11.5M | $10.9M | $6.4M | $11.2M | $14.7M | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$168.0K | -$141.0K | -$456.0K | $610.0K | $98.0K | |
| Increase Decrease In Inventories | $13.0K | $961.0K | -$295.0K | $892.0K | -$621.0K | |
| Increase Decrease In Accounts Payable Trade | -$9.0K | -$206.0K | $81.0K | -$169.0K | $164.0K | |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $112.0K | -$97.0K | -$156.0K | $113.0K | $18.0K | |
| Proceeds From Issuing Shares | 7.2M | 15.7M | 7.4M | |||
| Payments Of Lease Liabilities Classified As Financing Activities | $647.0K | $546.0K | $497.0K | |||
| Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes | -$986.0K | $5.9M | $2.0M | |||
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -$786.0K | $63.0K | -$40.0K | |||
| Stock Issued During Period Value Share Based Compensation | $1.5M | $1.1M | $1.8M | $1.6M | $498.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 408.8K | 149.6K | 55.8K | 1.5M | 1.2M | |
| Weighted Average Number Of Diluted Shares Outstanding | 408.8K | 149.6K | 55.8K | 1.5M | 1.2M | |
| Earnings Per Share Diluted | $-57.14 | $-45.27 | $-174.63 | $-7.58 | $-9.23 | |
| Earnings Per Share Basic | $-57.14 | $-45.27 | $-174.63 | $-7.58 | $-9.23 | |
| Diluted Earnings Loss Per Share | $-0.76 | $-0.94 | $-1.19 | |||
| Basic Earnings Loss Per Share | $-0.76 | $-0.87 | $-1.19 | |||
| Common Stock Shares Issued | 715.9K | 231.3K | 2.2M | 1.5M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stock Issued During Period Value New Issues | $5.7M | $8.2M | $6.5M | $7.2M | $15.7M | |
| Other Operating Income Expense Net | $1.0K | -$234.0K | $37.0K | -$737.0K | -$295.0K | |
| Noncash Interest And Exchange Rate Differences Net | $567.0K | -$101.0K | -$94.0K | -$560.0K | $54.0K | |
| Issued Capital | $88.0K | $79.0K | $1.4M | |||
| Depreciation | $561.0K | $228.0K | $120.0K | $239.0K | $250.0K | |
| Other Operating Income Expense | -$11.6M | -$11.1M | -$9.3M | |||
| Other Financial Expenses | $348.0K | $187.0K | $384.0K | |||
| Interest Payments | $69.0K | $179.0K | $107.0K | |||
| Installation Of A Production Line Less Participation By The Israeli Innovation Authority | $1.4M | $193.0K | $416.0K | |||
| Increase Decrease Through Sharebased Payment Transactions | $1.5M | $507.0K | $137.0K | |||
| Finance Income Cost | $561.0K | $718.0K | -$151.0K | |||
| Finance Income | $919.0K | $1.1M | $963.0K | |||
| Finance Costs | $358.0K | $355.0K | $1.1M | |||
| Currency Translation Differences | -$529.0K | -$14.0K | -$64.0K | |||
| Adjustments For Sharebased Payments | $1.5M | $507.0K | $137.0K | |||
| Adjustments For Provisions | -$183.0K | $150.0K | $63.0K | |||
| Adjustments For Depreciation Expense | $239.0K | $250.0K | $220.0K | |||
| Adjustments For Decrease Increase In Inventories | -$894.0K | $507.0K | -$400.0K | |||
| Issuance Of Shares And Warrants | 7.2M | 7.4M | ||||
| Exercise Of Options And Warrants | $3.0K | $104.0K | $20.0K | $584.0K | ||
| Installation Of A Production Facility Less Participation By The Israeli Innovation Authority | $306.0K | $2.6M | $1.4M | $193.0K | ||
| Borrowing Costs Capitalized | $53.0K | $175.0K | $20.0K |
Most recent annual filing with the SEC: March 25, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.